-14.6%
MRNA vs RCAT
-6.9%
-7.7%
-93.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | RCAT | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.9% | -31.7% | +27.8% | -1.2% |
| 7D | -17.6% | -42.8% | +25.2% | -14.0% |
| 30D | -5.1% | -48.9% | +43.8% | -0.3% |
| 3M | +220.8% | -76.9% | +297.7% | +258.0% |
| 6M | +321.7% | -74.6% | +396.3% | +362.4% |
| YTD | +601.3% | -69.6% | +670.9% | +649.4% |
| 1Y | +735.2% | -64.4% | +799.6% | +781.2% |
| 3Y | +170.5% | +173.9% | -3.3% | +134.1% |
| 5Y | -14.6% | -4.4% | -10.3% | -20.8% |
| All | -14.6% | -6.9% | -7.7% | -20.8% |
Cumulative growth
Daily Returns
Daily percentage return beside RCAT.
Daily Out/Under-Performance
Portfolio return minus RCAT return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RCAT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded RCAT wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling